Stocks · Health care · Pharmaceutical Preparations

Arcus Biosciences, Inc.

RCUS Clue Score44
United States Fiscal year ends December CIK 0001724521 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Alexander Azoy
21 Aug 2026
Chief Accounting Officer
Sold after exercise
2,827
$30.00
$84.81K
Alexander Azoy
26 Nov 2025
Chief Accounting Officer
Sold after exercise
1,900
$26.00
$49.40K
Jennifer Jarrett
7 Nov 2025
Chief Operating Officer
Sold after exercise
50,291
$18.97
$954.07K
Jennifer Jarrett
8 Oct 2025
Chief Operating Officer
Sold after exercise
37,792
$15.05
$568.61K
Jennifer Jarrett
6 Oct 2025
Chief Operating Officer
Sold after exercise
12,500
$14.54
$181.80K

What was left out

Form 4 filings counted 258
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 61
Sales straight out of an exercise 5
Sales at will 85
Transactions with no price 0
Shares from compensation/vesting 20,866,287
Sales filed before the plan box existed 84
History held since 19 Mar 2018